Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio Now
https://www.zacks.com/stock/news/2204955/reasons-to-retain-shockwave-medical-swav-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2204955
Jan 03, 2024 - ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.
0
Here's Why Investors Should Retain Abbott (ABT) Stock Now
https://www.zacks.com/stock/news/2207160/here-s-why-investors-should-retain-abbott-abt-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2207160
Jan 08, 2024 - Investors are optimistic about Abbott (ABT) led by solid prospects in the Diagnostic business and raised guidance.
0
QIAGEN (QGEN) Gains From New Alliances Amid FX Headwind
https://www.zacks.com/stock/news/2207546/qiagen-qgen-gains-from-new-alliances-amid-fx-headwind?cid=CS-ZC-FT-analyst_blog|zer_report_update-2207546
Jan 09, 2024 - QIAGEN (QGEN) is progressing well with its testing menu expansion strategy, which is driving the company's growth.
0
Veradigm (MDRX) & MedAllies Partner for Better Care Decisions
https://www.zacks.com/stock/news/2208303/veradigm-mdrx-medallies-partner-for-better-care-decisions?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208303
Jan 10, 2024 - Veradigm's (MDRX) partnership with MedAllies is likely to gain access to a wider range of patient data and drive better treatment decisions.
0
Strength Seen in Integer (ITGR): Can Its 3.8% Jump Turn into More Strength?
https://www.zacks.com/stock/news/2209378/strength-seen-in-integer-itgr-can-its-3-8-jump-turn-into-more-strength?cid=CS-ZC-FT-tale_of_the_tape|daily_price_change_3%-2209378
Jan 12, 2024 - Integer (ITGR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
0
Here's Why You Should Retain CONMED (CNMD) Stock for Now
https://www.zacks.com/stock/news/2210112/here-s-why-you-should-retain-conmed-cnmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210112
Jan 15, 2024 - CONMED (CNMD) continues to raise optimism among investors, owing to its broad product spectrum.
0
Veeva Systems (VEEV) Offerings Adopted by SK Life Science
https://www.zacks.com/stock/news/2210243/veeva-systems-veev-offerings-adopted-by-sk-life-science?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210243
Jan 15, 2024 - Veeva Systems' (VEEV) Vault Validation Management is expected to aid SK Life Science to accelerate validation processes for increased inspection readiness.
0
Stryker's (SYK) New Tech Aims to Improve Surgeon's Efficiency
https://www.zacks.com/stock/news/2210235/stryker-s-syk-new-tech-aims-to-improve-surgeon-s-efficiency?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210235
Jan 15, 2024 - Stryker's (SYK) Blueprint Mixed Reality Guidance system aims to benefit shoulder arthroplasty surgeons by improving efficiency and minimizing errors.
0
Here's Why You Should Retain Masimo (MASI) Stock for Now
https://www.zacks.com/stock/news/2210710/here-s-why-you-should-retain-masimo-masi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2210710
Jan 16, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
0
PacBio's (PACB) New PanDNA Kit Ready to Boost DNA Extraction
https://www.zacks.com/stock/news/2210985/pacbio-s-pacb-new-pandna-kit-ready-to-boost-dna-extraction?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2210985
Jan 16, 2024 - PacBio's (PACB) new offering, PanDNA kit, is likely to help researchers effectively extract DNA optimized for HiFi sequencing. This versatile Nanobind kit is expected to be available in February 2024.
0